By Dr Claire Deakin

Journal articles

Yasin SA; Schutz PW; Deakin CT; Sag E; Varsani H; Simou S; Tansley S; McHugh N; Holton JL; Wedderburn LR; Jacques TS, 2017, 'Biopsy pathology in a large cohort of juvenile dermatomyositis is heterogeneous and, for the most part, independent of autoantibody phenotype', Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 44, pp. S6 - S6, http://dx.doi.org/10.1017/cjn.2017.17

Tansley SL; Shaddick G; Simou S; Betteridge Z; Deakin C; Soponkanaporn S; Gunawardena H; Wedderburn L; McHugh N, 2017, 'CONNECTIVE TISSUE DISORDERS AND VASCULITIS ORAL ABSTRACTSO13. AUTOANTIBODY SUBTYPE IN PATIENTS WITH JUVENILE-ONSET MYOSITIS INFLUENCES TREATMENT RECEIVED', Rheumatology, 56, http://dx.doi.org/10.1093/rheumatology/kex061.013

Deakin CT; Yasin SA; Simou S; Arnold KA; Tansley SL; Betteridge ZE; McHugh NJ; Varsani H; Holton JL; Jacques TS; Pilkington CA; Nistala K; Wedderburn LR; Armon K; Ellis-Gage J; Roper H; Briggs V; Watts J; McCann L; Roberts I; Baildam E; Hanna L; Lloyd O; Wadeson S; Riley P; McGovern A; Ryder C; Scott J; Thomas B; Southwood T; Al-Abadi E; Wyatt S; Jackson G; Amin T; Wood M; VanRooyen V; Burton D; Davidson J; Gardner-Medwin J; Martin N; Ferguson S; Waxman L; Browne M; Friswell M; Swift A; Jandial S; Stevenson V; Wade D; Sen E; Smith E; Qiao L; Watson S; Duong C; Venning H; Satyapal R; Stretton E; Jordan M; Mosley E; Frost A; Crate L; Warrier K; Stafford S; Hasson N; Maillard S; Halkon E; Brown V; Juggins A; Smith S; Lunt S; Enayat E; Kassoumeri L; Beard L; Glackin Y; Almeida B; Marques R; Dowle S; Papadopoulou C; Murray K; Ioannou J; Suffield L; Al-Obaidi M; Lee H; Leach S; Smith H; McMahon AM; Chisem H; Kingshott R; Wilkinson N; Inness E; Kendall E; Mayers D; Etherton R; Bailey K; Clinch J; Fineman N; Pluess-Hall H; Vallance L; Akeroyd L; Leahy A; Collier A, 2016, 'Muscle Biopsy Findings in Combination With Myositis-Specific Autoantibodies Aid Prediction of Outcomes in Juvenile Dermatomyositis', Arthritis and Rheumatology, 68, pp. 2806 - 2816, http://dx.doi.org/10.1002/art.39753

Campanilho-Marques R; Almeida B; Deakin C; Arnold K; Gallot N; de Iorio M; Nistala K; Pilkington CA; Wedderburn LR; Armon K; Ellis-Gage J; Roper H; Briggs V; Watts J; McCann L; Roberts I; Baildam E; Hanna L; Lloyd O; Riley P; McGovern A; Ryder C; Scott J; Thomas B; Southwood T; Al-Abadi E; Wyatt S; Jackson G; Amin T; Wood M; VanRooyen V; Burton D; Davidson J; Gardner-Medwin J; Martin N; Ferguson S; Waxman L; Browne M; Friswell M; Foster H; Swift A; Jandial S; Stevenson V; Wade D; Sen E; Smith E; Qiao L; Watson S; Venning H; Satyapal R; Stretton E; Jordan M; Mosley E; Frost A; Crate L; Warrier K; Hasson N; Maillard S; Halkon E; Brown V; Juggins A; Smith S; Lunt S; Enayat E; Varsani H; Kassoumeri L; Beard L; Glackin Y; Simou S; Murray K; Ioannou J; Suffield L; Al-Obaidi M; Lee H; Leach S; Smith H; Wilkinson N; Inness E; Kendall E; Mayers D; Clinch J; Pluess-Hall H, 2016, 'Comparison of the Utility and Validity of Three Scoring Tools to Measure Skin Involvement in Patients With Juvenile Dermatomyositis', Arthritis Care and Research, 68, pp. 1514 - 1521, http://dx.doi.org/10.1002/acr.22867

Deakin CT; Deakin JJ; Ginn SL; Young P; Humphreys D; Suter CM; Alexander IE; Hallwirth CV, 2014, 'Impact of next-generation sequencing error on analysis of barcoded plasmid libraries of known complexity and sequence', NUCLEIC ACIDS RESEARCH, 42, http://dx.doi.org/10.1093/nar/gku607

Deakin CT; Alexander IE; Hooker CA; Kerridge IH, 2013, 'Gene therapy researchers' assessments of risks and perceptions of risk acceptability in clinical trials', Molecular Therapy, 21, pp. 806 - 815, http://dx.doi.org/10.1038/mt.2012.230

Deakin CT; Alexander IE; Kerridge I, 2010, 'The ethics of gene therapy: Balancing the risks', Current Opinion in Molecular Therapeutics, 12, pp. 578 - 585

Bennett B; Deakin C, 2009, 'Registration of clinical trials: challenges for global regulation.', Journal of Law and Medicine, 17, pp. 82 - 94

Deakin CT; Alexander IE; Kerridge I, 2009, 'Accepting risk in clinical research: Is the gene therapy field becoming too risk-averse?', Molecular Therapy, 17, pp. 1842 - 1848, http://dx.doi.org/10.1038/mt.2009.223

Deakin C, 2008, 'Resolving the regulatory conflict: Lessons for Australia from the European experience of regulating the release of genetically modified organisms into the environment', Environmental and Planning Law Journal, 25, pp. 22 - 48

Smyth CM; Ginn SL; Deakin CT; Logan GJ; Alexander IE, 2007, 'Limiting γc expression differentially affects signaling via the interleukin (IL)-7 and IL-15 receptors', Blood, 110, pp. 91 - 98, http://dx.doi.org/10.1182/blood-2006-11-055442

Back to profile page